Target intelligence / Profile preview

Systemic pharmacokinetics (PK)

Target
PK
01

Overview

Systemic pharmacokinetics refers to the quantitative study of how a drug substance is absorbed, distributed, metabolized, and excreted (ADME) by the body over time (StatPearls: Pharmacokinetics, 2023). It is not a biological target such as a receptor, enzyme, or transporter, but rather a pharmacological concept describing the movement of a drug through the systemic circulation and tissues (Merck Manual: Overview of Pharmacokinetics, 2022). Key parameters like clearance, volume of distribution, and half-life are utilized to determine optimal dosing regimens and predict drug behavior across diverse patient populations (FDA: Clinical Pharmacology Section of Labeling, 2016). Understanding systemic pharmacokinetics is essential for ensuring that a drug reaches its intended molecular target at a concentration that is both effective and safe. Factors such as age, genetics (pharmacogenomics), and underlying disease states can significantly alter these processes, necessitating dose adjustments to avoid toxicity or therapeutic failure.

Other names
ADMEPharmacokineticsDrug dispositionClinical pharmacokinetics
02

Mechanism of action

Not applicable

03

Biological functions

Drug absorptionDrug distributionDrug metabolismDrug excretion
04

Safety considerations

Drug-drug interactionsAccumulation toxicity in renal or hepatic impairmentSub-therapeutic dosing due to rapid metabolismNarrow therapeutic index
05

Biomarkers

Area under the curve (AUC)Maximum concentration (Cmax)Half-life (t1/2)Clearance (CL)Volume of distribution (Vd)Bioavailability (F)

Beyond the preview

Go deeper on Systemic pharmacokinetics (PK).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Systemic pharmacokinetics (PK).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call